Gerard Rubí-Sans

Mr. Gerard Rubí-Sans

Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST)
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2022 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
BBBarbara Blanco-Fernandez
Barbara Blanco-Fernandez
SRSergi Rey-Vinolas
Sergi Rey-Vinolas
GBGülsün Bağcı
Gülsün Bağcı
GRGerard Rubí-Sans
Gerard Rubí-Sans
JOJorge Otero
Jorge Otero
EEElisabeth Engel
Elisabeth Engel
The tumor extracellular matrix (ECM) plays a vital role in tumor progression and drug resistance. Previous studies have shown that breast tissue-derived matrices could be an important biomaterial to recreate the complexity of the tumor ECM. We have developed a method for decellularizing and delipidating a porcine breast tissue (TDM) compatible with hydrogel formation. The addition of gelatin methacrylamide and alginate allows this TDM to be bioprinted by itself with good printability, shape fidelity, and cytocompatibility. Furthermore, this bioink has been tuned to more closely recreate the breast tumor by incorporating collagen type I (Col1). Breast cancer cells (BCCs) proliferate in both TDM bioinks forming cell clusters and spheroids. The addition of Col1 improves the printability of the bioink as well as increases BCC proliferation and reduces doxorubicin sensitivity due to a downregulation of HSP90. TDM bioinks also allow a precise three-dimensional printing of scaffolds containing BCCs and stromal cells and could be used to fabricate artificial tumors. Taken together, we have proven that these novel bioinks are good candidates for biofabricating breast cancer models.

8 September 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
GRGerard Rubí-Sans
Gerard Rubí-Sans
ANAgata Nyga
Agata Nyga
ERElena Rebollo
Elena Rebollo
SPSoledad Pérez-Amodio
Soledad Pérez-Amodio
JOJorge Otero
Jorge Otero
EEElisabeth Engel
Elisabeth Engel

1 July 2020 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
GRGerard Rubí-Sans
Gerard Rubí-Sans
OCOscar Castaño
Oscar Castaño
ICIrene Cano
Irene Cano
MTMiguel Angel Mateos Timoneda
Miguel Angel Mateos Timoneda
SPSoledad Perez-Amodio
Soledad Perez-Amodio
EEElisabeth Engel
Elisabeth Engel

28 December 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
GRGerard Rubí-Sans
Gerard Rubí-Sans
LRLourdes Recha-Sancho
Lourdes Recha-Sancho
SPSoledad Perez-Amodio
Soledad Perez-Amodio
MTMiguel Angel Mateos Timoneda
Miguel Angel Mateos Timoneda
Carlos E. SeminoCarlos E. Semino
Carlos E. Semino
EEElisabeth Engel
Elisabeth Engel
Degenerative cartilage pathologies are nowadays a major problem for the world population. Factors such as age, genetics or obesity can predispose people to suffer from articular cartilage degeneration, which involves severe pain, loss of mobility and consequently, a loss of quality of life. Current strategies in medicine are focused on the partial or total replacement of affected joints, physiotherapy and analgesics that do not address the underlying pathology. In an attempt to find an alternative therapy to restore or repair articular cartilage functions, the use of bioengineered tissues is proposed. In this study we present a three-dimensional (3D) bioengineered platform combining a 3D printed polycaprolactone (PCL) macrostructure with RAD16-I, a soft nanofibrous self-assembling peptide, as a suitable microenvironment for human mesenchymal stem cells’ (hMSC) proliferation and differentiation into chondrocytes. This 3D bioengineered platform allows for long-term hMSC culture resulting in chondrogenic differentiation and has mechanical properties resembling native articular cartilage. These promising results suggest that this approach could be potentially used in articular cartilage repair and regeneration.

25 February 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
GRGerard Rubí-Sans
Gerard Rubí-Sans
ICIrene Cano-Torres
Irene Cano-Torres
SPSoledad Perez-Amodio
Soledad Perez-Amodio
BBBarbara Blanco-Fernandez
Barbara Blanco-Fernandez
MTMiguel Angel Mateos Timoneda
Miguel Angel Mateos Timoneda
EEElisabeth Engel
Elisabeth Engel
Tissue engineering and regenerative medicine approaches use biomaterials in combination with cells to regenerate lost functions of tissues and organs to prevent organ transplantation. However, most of the current strategies fail in mimicking the tissue’s extracellular matrix properties. In order to mimic native tissue conditions, we developed cell-derived matrix (CDM) microtissues (MT). Our methodology uses poly-lactic acid (PLA) and Cultispher® S microcarriers’ (MCs’) as scaffold templates, which are seeded with rat bone marrow mesenchymal stem cells (rBM-MSCs). The scaffold template allows cells to generate an extracellular matrix, which is then extracted for downstream use. The newly formed CDM provides cells with a complex physical (MT architecture) and biochemical (deposited ECM proteins) environment, also showing spontaneous angiogenic potential. Our results suggest that MTs generated from the combination of these two MCs (mixed MTs) are excellent candidates for tissue vascularization. Overall, this study provides a methodology for in-house fabrication of microtissues with angiogenic potential for downstream use in various tissue regenerative strategies.

14 January 2015 in Current Stem Cell Research & Therapy
Verified
Journal Article
Closed access
PDF file
CNCristian A. Núñez-Espinosa
Cristian A. Núñez-Espinosa
IFInes Ferreira
Ines Ferreira
JRJuan Gabriel Rios-Kristjansson
Juan Gabriel Rios-Kristjansson
DRDavid Rizo-Roca
David Rizo-Roca
MGMaria Dolors Garcia Godoy
Maria Dolors Garcia Godoy
Ginés ViscorGinés Viscor
Ginés Viscor
Our goal was to address if intermittent hypobaric hypoxia (IHH) exposure can help to increase the number of peripheral blood circulating progenitor cells and side population (SP) stem cells, in order to establish the usefulness of this intervention for skeletal muscle repair, because these cells play a role in tissue regeneration. Male Sprague-Dawley rats were studied in two basal states: untrained and trained and compared with 1, 3, 7 and 14 days stages of damage recovery of trained rats that had suffered skeletal muscle injury. Three experimental groups were studied: rats with passive recovery (CTRL); rats exposed to IHH after muscle damage (HYP); and, trained rats that, in addition to IHH, performed light aerobic exercise sessions (EHYP). We observed an increase in hematopoietic stem cells (HSCs) (mean = 0.153% of cells) and endothelial progenitor cells (EPCs) (mean = 0.0020 % of cells) in EHYP on day 7. Also these cells showed characteristics of more primitive progenitors in comparison to the other experimental groups (mean = 0.107 % of cells), as deduced by retention of the promising fluorescent probe Vybrant Dye Cycle Violet. We concluded that intermittent exposure to hypobaric hypoxia in combination with light aerobic exercise increased the number of HSCs and EPCs on the 7th day in EHYP group, although the exercise-induced stimulus showed a reverse effect on SP kinetics.